# Multi-Omics Analyses Unveil the Effects of a Long-Term High-Salt, High-Fat, and High-Fructose Diet on Rats

**Authors:** Yue Yao, Xiao Wu, Hao Wu, Weiwei Su, Peibo Li

PMC · DOI: 10.3390/foods15010171 · Foods · 2026-01-04

## TL;DR

A long-term diet high in salt, fat, and fructose harms rats' metabolism, brain health, and gut bacteria, increasing risks of neurodegenerative diseases.

## Contribution

This study reveals how a combined high-salt, high-fat, and high-fructose diet affects brain and gut health through multi-omics analyses.

## Key findings

- The diet increased blood glucose, blood pressure, and harmful serum lipid levels in rats.
- Brain proteomic and metabolomic changes included glial cell proliferation and altered fatty acid metabolism.
- Gut microbiome disruption and elevated neuroinflammation suggest a link to neurodegenerative risks.

## Abstract

Background: Unhealthy diets characterized by high salt, fat, and fructose content are established risk factors for metabolic and cardiovascular disorders and may have indirect effects on cognitive function. However, the combined impact of a high-salt, high-fat, and high-fructose diet (HSHFHFD) on systemic physiology and brain health remains to be fully elucidated. Methods: Sprague-Dawley (SD) rats received a customized high-salt, high-fat diet supplemented with 30% fructose water for 18 weeks. Physiological and brain parameters were assessed, in combination with multi-omics analyses including brain proteomics and metabolomics, serum metabolomics, and gut microbiota profiling. Results: HSHFHFD significantly elevated blood glucose, blood pressure, and serum levels of TG, TC, and LDL in rats. Serum metabolomic profiling identified over 100 differentially abundant metabolites in the Model group. Proteomics, metabolomics, and gut microbiome integration revealed pronounced alterations in both brain proteomic and metabolomic profiles, with 155 differentially expressed proteins associated with glial cell proliferation and 65 differential metabolites linked to fatty acid and amino acid metabolism, among others. Experimental validation confirmed marked upregulation of GFAP and Bax protein, concomitant with downregulation of ZO-1 and occludin. Furthermore, HSHFHFD perturbed the CREB signaling pathway, leading to diminished BDNF expression. The levels of inflammatory factors, including IL-6, IL-10, IL-1β and TNFα, were significantly elevated in the brain. Oxidative stress was evident, as indicated by elevated malondialdehyde (MDA) levels, increased superoxide dismutase (SOD) activity, and altered NAD+/NADH ratio. Additionally, HSHFHFD significantly reduced the abundance of beneficial gut bacteria, including Lactobacillus, Romboutsia, and Monoglobus. Conclusions: HSHFHFD-induced depletion of gut Lactobacillus spp. may disrupt the linoleic acid metabolic pathway and gut–brain axis homeostasis, leading to the impairment of neuroprotective function, blood–brain barrier dysfunction, and exacerbated neuroinflammation and oxidative stress in the brain. These effects potentially increase the susceptibility of rats to neurodegenerative disorders.

## Linked entities

- **Proteins:** GFAP (glial fibrillary acidic protein), BAX (BCL2 associated X, apoptosis regulator), TJP1 (tight junction protein 1), si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3), CREB1 (cAMP responsive element binding protein 1), BDNF (brain derived neurotrophic factor), IL6 (interleukin 6), IL10 (interleukin 10), IL1B (interleukin 1 beta), TNF (tumor necrosis factor), SOD1 (superoxide dismutase 1), so (sine oculis)
- **Chemicals:** fructose (PubChem CID 5984), TG (PubChem CID 2723601), TC (PubChem CID 23957), NAD+ (PubChem CID 5892), NADH (PubChem CID 439153)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Gfap (glial fibrillary acidic protein) [NCBI Gene 24387], Ocln (occludin) [NCBI Gene 83497], Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], Tjp1 (tight junction protein 1) [NCBI Gene 292994] {aka ZO-1}
- **Diseases:** inflammatory (MESH:D007249), neurodegenerative disorders (MESH:D019636), neuroinflammation (MESH:D000090862), metabolic and cardiovascular disorders (MESH:D024821)
- **Chemicals:** fatty acid (MESH:D005227), Fat (MESH:D005223), TG (MESH:D013866), NAD+ (MESH:D009243), glucose (MESH:D005947), Salt (MESH:D012492), amino acid (MESH:D000596), TC (MESH:D013667), linoleic acid (MESH:D019787), Fructose (MESH:D005632), MDA (MESH:D008315)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], gut metagenome (species) [taxon 749906], Lactobacillus (genus) [taxon 1578], Monoglobus (genus) [taxon 2039302]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12785590/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12785590/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC12785590/full.md

---
Source: https://tomesphere.com/paper/PMC12785590